Investigators describe a compound known as Hinokitiol which can correct iron-delivery defects in preclinical models. Their study lays the groundwork for investigating Hinkitiol’s full potential beyond cellular and model organisms.
Investigators describe a compound known as Hinokitiol which can correct iron-delivery defects in preclinical models. Their study lays the groundwork for investigating Hinkitiol’s full potential beyond cellular and model organisms.